Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 5/20 | 0.39 |
| ▸ | CA2 | P00918 | 5/20 | 0.39 |
| ▸ | CA12 | O43570 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.33 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.33 |
| ▸ | CD69 | Q07108 | 1/20 | 0.32 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16508656 | 1.00 | OGA (0.44) | OGACA9CA2CA12CA1 | |
| SCHEMBL13341455 | 1.00 | OGA (0.44) | OGACA9CA2CA12CA1 | |
| SCHEMBL18239034 | 1.00 | OGA (0.44) | OGACA9CA2CA12CA1 | |
| SCHEMBL16492114 | 0.94 | OGA (0.42) | OGACA9CA2CA12CA1 | |
| SCHEMBL16743504 | 0.94 | OGA (0.46) | OGACA9CA2CA12CA1 | |
| SCHEMBL15730189 | 0.94 | OGA (0.42) | OGACA9CA2CA12CA1 | |
| SCHEMBL15451493 | 0.94 | OGA (0.46) | OGACA9CA2CA12CA1 | |
| SCHEMBL7538718 | 0.94 | OGA (0.46) | OGACA9CA2CA12CA1 | |
| SCHEMBL16315909 | 0.94 | OGA (0.42) | OGACA9CA2CA12CA1 | |
| SCHEMBL15730547 | 0.94 | OGA (0.42) | OGACA9CA2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE46144-E1 | Hydroxamic acid derivatives | PURDUE PHARMACEUTICAL PRODUCTS L.P. (US) | 2016-09-13 | — | — | US | disclosed |